RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/s-0042-1749370
Role of Probiotics in Patients with Allergic Rhinitis: A Systematic Review of Systematic Reviews
Authors
Abstract
Introduction Allergic rhinitis (AR) is estimated to affect up to 30% of the world population. With the rise in cases, newer treatment modalities have been explored. Probiotics have shown to reduce symptoms of AR and improve quality of life. A few systematic reviews have been published aiming to assess the role of probiotics in AR.
Objectives To consolidate the recent evidence with an overview of systematic reviews by extracting data regarding subjective outcomes (from quality of life questionnaires, the Total Nasal Symptom Score, the Total Ocular Symptom Score, the Daily Total Symptom Score, the incidence of AR, and the Rhinitis Total Symptom Score) and objective outcomes (levels of antigen-specific immunoglobulin E [IgE], total IgE, interleukin 10 [IL-10], interferon gamma [IFNG], eosinophil, and the T helper 1/T helper 2 [Th1/Th2] ratio).
Data Synthesis We conducted a literature search on the PubMed, EBSCO CINAHL, EBSCO Dentistry & Oral Sciences Source, and Cochrane Library up to April 14, 2020. The qualitative assessment was performed using the Assessing the Methodological Quality of Systematic Reviews (AMSTAR-2) tool. A total of 419 titles were screened, and 3 systematic reviews met our eligibility criteria. Probiotics in the treatment of AR have been shown to improve quality of life, the total nasal and ocular symptom scores, the daily total symptom scores and Th1/Th2 ratio. No difference was ascertained for rhinitis total symptom score, and the rates of antigen-specific IgE, total IgE, IL-10, INFG and eosinophil.
Conclusion The present review showed that there is considerable evidence that probiotics are useful in the treatment of AR. Further randomized trials targeting the limitations of the currently-available evidence can help ascertain the usefulness of probiotics in cases of AR.
Financial Support
The authors declare that they have not received financial support regarding the performance of the present study.
Publikationsverlauf
Eingereicht: 30. Oktober 2021
Angenommen: 17. April 2022
Artikel online veröffentlicht:
17. Juni 2022
© 2022. Fundação Otorrinolaringologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Bousquet J, Khaltaev N, Cruz AA. et al; World Health Organization, GA(2)LEN, AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63 (Suppl 86): 08-160
- 2 Pawankar R, Canonica GW, Holgate ST, Lockey RF, Blaiss MS. WAO white book on allergy. Milwaukee: WI World Allergy Organ; 2011. 3. 156-157
- 3 Small P, Kim H. Allergic rhinitis. Allergy Asthma Clin Immunol 2011; 7 (1, Suppl 1) S3
- 4 Peng Y, Li A, Yu L, Qin G. The role of probiotics in prevention and treatment for patients with allergic rhinitis: A systematic review. Am J Rhinol Allergy 2015; 29 (04) 292-298
- 5 Strachan DP, Warner J, Pickup J, Schweiger MPH, Stanwell-Smith R, Jones M. The hygiene hypothesis. BMJ 1989; 299: 1259-1260
- 6 Borchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin ME. Probiotics and immunity. J Gastroenterol 2009; 44 (01) 26-46
- 7 Christodoulopoulos P, Cameron L, Durham S, Hamid Q. Molecular pathology of allergic disease. II: Upper airway disease. J Allergy Clin Immunol 2000; 105 (2 Pt 1): 211-223
- 8 Özdemir O. Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data. Clin Exp Immunol 2010; 160 (03) 295-304
- 9 Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota?. Nat Rev Microbiol 2009; 7 (12) 887-894
- 10 Ouwehand AC, Nermes M, Collado MC, Rautonen N, Salminen S, Isolauri E. Specific probiotics alleviate allergic rhinitis during the birch pollen season. World J Gastroenterol 2009; 15 (26) 3261-3268
- 11 Zajac AE, Adams AS, Turner JH. A systematic review and meta‐analysis of probiotics for the treatment of allergic rhinitis. In: International forum of allergy & rhinology. Wiley Online Library; 2015: 524-532
- 12 Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Vol. 5,. The Cochrane Collaboration; 2009
- 13 Liberati A, Altman DG, Tetzlaff J. et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339: b2700
- 14 Güvenç IA, Muluk NB, Mutlu FŞ. et al. Do probiotics have a role in the treatment of allergic rhinitis? A comprehensive systematic review and meta-analysis. Am J Rhinol Allergy 2016; 30 (05) 157-175
- 15
Shea BJ,
Reeves BC,
Wells G.
et al.
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised
or non-randomised studies of healthcare interventions, or both. BMJ 2017; 358: j4008
Reference Ris Wihthout Link
- 16 Wang MF, Lin HC, Wang YY, Hsu CH. Treatment of perennial allergic rhinitis with lactic acid bacteria. Pediatr Allergy Immunol 2004; 15 (02) 152-158
- 17 Peng G-C, Hsu C-H. The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite. Pediatr Allergy Immunol 2005; 16 (05) 433-438
- 18 Yonekura S, Okamoto Y, Okawa T. et al. Effects of daily intake of Lactobacillus paracasei strain KW3110 on Japanese cedar pollinosis. Allergy Asthma Proc 2009; 30 (04) 397-405
- 19 Costa DJ, Marteau P, Amouyal M. et al. Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial (GA2LEN Study). Eur J Clin Nutr 2014; 68 (05) 602-607
- 20 Lin W-Y, Fu L-S, Lin H-K, Shen C-Y, Chen Y-J. Evaluation of the effect of Lactobacillus paracasei (HF.A00232) in children (6-13 years old) with perennial allergic rhinitis: a 12-week, double-blind, randomized, placebo-controlled study. Pediatr Neonatol 2014; 55 (03) 181-188
- 21 Nishimura I, Igarashi T, Enomoto T, Dake Y, Okuno Y, Obata A. Clinical efficacy of halophilic lactic acid bacterium Tetragenococcus halophilus Th221 from soy sauce moromi for perennial allergic rhinitis. Allergol Int 2009; 58 (02) 179-185
- 22 Kawase M, He F, Kubota A. et al. Effect of fermented milk prepared with two probiotic strains on Japanese cedar pollinosis in a double-blind placebo-controlled clinical study. Int J Food Microbiol 2009; 128 (03) 429-434
- 23 Singh A, Hacini-Rachinel F, Gosoniu ML. et al. Immune-modulatory effect of probiotic Bifidobacterium lactis NCC2818 in individuals suffering from seasonal allergic rhinitis to grass pollen: an exploratory, randomized, placebo-controlled clinical trial. Eur J Clin Nutr 2013; 67 (02) 161-167
- 24 Lin T-Y, Chen C-J, Chen L-K, Wen S-H, Jan R-H. Effect of probiotics on allergic rhinitis in Df, Dp or dust-sensitive children: a randomized double blind controlled trial. Indian Pediatr 2013; 50 (02) 209-213
- 25 Xiao JZ, Kondo S, Yanagisawa N. et al. Effect of probiotic Bifidobacterium longum BB536 [corrected] in relieving clinical symptoms and modulating plasma cytokine levels of Japanese cedar pollinosis during the pollen season. A randomized double-blind, placebo-controlled trial. J Investig Allergol Clin Immunol 2006; 16 (02) 86-93
- 26 Xiao J-Z, Kondo S, Yanagisawa N. et al. Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial. Clin Exp Allergy 2006; 36 (11) 1425-1435
- 27 Okubo K, Kurono Y, Fujieda S. et al; Japanese Society of Allergology. Japanese guideline for allergic rhinitis. Allergol Int 2011; 60 (02) 171-189
- 28 Dotterud CK, Storrø O, Johnsen R, Oien T. Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. Br J Dermatol 2010; 163 (03) 616-623
- 29 Kalliomäki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003; 361 (9372): 1869-1871
- 30 Kuitunen M, Kukkonen K, Juntunen-Backman K. et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol 2009; 123 (02) 335-341
- 31 Kukkonen AK, Kuitunen M, Savilahti E, Pelkonen A, Malmberg P, Mäkelä M. Airway inflammation in probiotic-treated children at 5 years. Pediatr Allergy Immunol 2011; 22 (02) 249-251
- 32 West CE, Hammarström M-L, Hernell O. Probiotics in primary prevention of allergic disease–follow-up at 8-9 years of age. Allergy 2013; 68 (08) 1015-1020
- 33 Helin T, Haahtela S, Haahtela T. No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy 2002; 57 (03) 243-246
- 34 Lue K-H, Sun H-L, Lu K-H. et al. A trial of adding Lactobacillus johnsonii EM1 to levocetirizine for treatment of perennial allergic rhinitis in children aged 7-12 years. Int J Pediatr Otorhinolaryngol 2012; 76 (07) 994-1001
- 35 Ciprandi G, Vizzaccaro A, Cirillo I, Tosca MA. Bacillus clausii effects in children with allergic rhinitis. Allergy 2005; 60 (05) 702-703
- 36 Nagata Y, Yoshida M, Kitazawa H, Araki E, Gomyo T. Improvements in seasonal allergic disease with Lactobacillus plantarum No. 14. Biosci Biotechnol Biochem 2010; 74 (09) 1869-1877
- 37 Ishida Y, Nakamura F, Kanzato H. et al. Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: a double-blind, placebo-controlled study. J Dairy Sci 2005; 88 (02) 527-533
- 38 Chen Y-S, Jan R-L, Lin Y-L, Chen H-H, Wang J-Y. Randomized placebo-controlled trial of lactobacillus on asthmatic children with allergic rhinitis. Pediatr Pulmonol 2010; 45 (11) 1111-1120
- 39 Giovannini M, Agostoni C, Riva E. et al; Felicita Study Group. A randomized prospective double blind controlled trial on effects of long-term consumption of fermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitis. Pediatr Res 2007; 62 (02) 215-220
- 40 Tamura M, Shikina T, Morihana T. et al. Effects of probiotics on allergic rhinitis induced by Japanese cedar pollen: randomized double-blind, placebo-controlled clinical trial. Int Arch Allergy Immunol 2007; 143 (01) 75-82
- 41 Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99 (02) 179-185
- 42 Kirjavainen PV, Gibson GR. Healthy gut microflora and allergy: factors influencing development of the microbiota. Ann Med 1999; 31 (04) 288-292
- 43 Rosenfeldt V, Benfeldt E, Nielsen SD. et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003; 111 (02) 389-395
- 44 Santos AR, Whorwell PJ. Irritable bowel syndrome: the problem and the problem of treating it - is there a role for probiotics?. Proc Nutr Soc 2014; 73 (04) 470-476
- 45 Xu J, Ma R, Chen L-F, Zhao L-J, Chen K, Zhang R-B. Effects of probiotic therapy on hepatic encephalopathy in patients with liver cirrhosis: an updated meta-analysis of six randomized controlled trials. Hepatobiliary Pancreat Dis Int 2014; 13 (04) 354-360